Chinese
Japan
English
FREE Beacon Chip upgrade from the 11k Chip to the 20k Chip.
Up to ~2x Screening Capacity
Increase the chance of obtaining desired sequences
This limited-time offer is valid for orders placed by March 31,2026.
Single B cell screening platform conducts isolation, screening, sorting, and evaluation on the B cells, avoiding the cell fusion and the library construction step, saving time from months to weeks. ProBio has upgraded the ProSpeed™ Single B Cell Antibody Discovery Platform, and integrated Bruker’s Beacon® technology with our proprietary ProSpeedTM expression. It is one of the disruptive, best-in-industry platforms for single B-cell screening, enabling customers to achieve fast and cost-effective discovery of confirmed functional antibody leads in as fast as 1 month.
ProBio‘s ProSpeed™ Single B Cell Antibody Discovery Platform is based on Beacon®, which combines optical positioning with microfluidic technology. It enables precise and efficient sorting of single cells into nano-pen chambers, completing diverse and robust assays within minutes. The desired clones were exported into 96 well plates for downstream HTP ProSpeedTM expression, further functional screening assay, and sequencing.
This single B cell screening technology maximizes our access to antibody repertoires, making it inherently superior in preserving B cell diversity, and the validated functional antibody sequences will be obtained as fast as 1 month.
The challenges in Beacon screening:
To address these limits effectively, we integrate the ProSpeedTM expression with Beacon® platform to allow fast and cost-effective discovery of functional Ab leads.
BMK1:Rovalpituzumab; BMK2:Tarlatamab-DLL3-lgG1
Accelerated Therapeutic Antibody Discovery via An Upgraded Beacon-based Single B Cell Ab Discovery Platform
Single B cell screening service using transgenic mice, as fast as 1 month to get fully human antibody sequence
Please download service quotation form and fill it before sending to us.